Literature DB >> 35449408

Novel lipid-lowering therapies targeting ANGPTL3 and Lp(a).

Gregory B Lim1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35449408     DOI： 10.1038/s41569-022-00715-8

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.

Authors:  Steven E Nissen; Kathy Wolski; Craig Balog; Daniel I Swerdlow; Alison C Scrimgeour; Curtis Rambaran; Rosamund J Wilson; Malcom Boyce; Kausik K Ray; Leslie Cho; Gerald F Watts; Michael Koren; Traci Turner; Erik S Stroes; Carrie Melgaard; Giles V Campion
Journal:  JAMA       Date:  2022-05-03       Impact factor: 157.335

2.  Effect of Vupanorsen on Non-High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70.

Authors:  Brian A Bergmark; Nicholas A Marston; Marc S Sabatine; Stephen D Wiviott; Candace R Bramson; Madelyn Curto; Vesper Ramos; Alexandra Jevne; Julia F Kuder; Jeong-Gun Park; Sabina A Murphy; Subodh Verma; Wojtek Wojakowski; Steven G Terra
Journal:  Circulation       Date:  2022-04-03       Impact factor: 39.918
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.